Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Inadequate assessment of adherence to maintenance medication leads to loss of power and increased costs in trials of severe asthma therapy: results from a systematic literature review and modelling study.

Mokoka MC, McDonnell MJ, MacHale E, Cushen B, Boland F, Cormican S, Doherty C, Doyle F, Costello RW, Greene G.

Eur Respir J. 2019 May 18;53(5). pii: 1802161. doi: 10.1183/13993003.02161-2018. Print 2019 May.

PMID:
30846467
2.

Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].

LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep.

3.
4.

Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.

Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM.

Cochrane Database Syst Rev. 2015 Nov 24;(11):CD007949. doi: 10.1002/14651858.CD007949.pub2. Review.

PMID:
26594816
5.

Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma.

Chauhan BF, Ben Salah R, Ducharme FM.

Cochrane Database Syst Rev. 2013 Oct 2;(10):CD009585. doi: 10.1002/14651858.CD009585.pub2. Review.

PMID:
24089325
6.

Inhaled corticosteroids in children with persistent asthma: effects on growth.

Zhang L, Prietsch SO, Ducharme FM.

Evid Based Child Health. 2014 Dec;9(4):829-930. doi: 10.1002/ebch.1988.

PMID:
25504972
7.

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma.

Evans DJ, Kew KM, Anderson DE, Boyter AC.

Cochrane Database Syst Rev. 2015 Jul 21;(7):CD011437. doi: 10.1002/14651858.CD011437.pub2. Review.

8.

Vilanterol and fluticasone furoate for asthma.

Dwan K, Milan SJ, Bax L, Walters N, Powell C.

Cochrane Database Syst Rev. 2016 Sep 1;9:CD010758. doi: 10.1002/14651858.CD010758.pub2. Review.

9.

Omalizumab for asthma in adults and children.

Normansell R, Walker S, Milan SJ, Walters EH, Nair P.

Cochrane Database Syst Rev. 2014 Jan 13;(1):CD003559. doi: 10.1002/14651858.CD003559.pub4. Review.

PMID:
24414989
10.

Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2004;4(7):1-98. Epub 2004 Jun 1.

11.

Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Henderson JT, Whitlock EP, O'Conner E, Senger CA, Thompson JH, Rowland MG.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr.

12.

Effect of inhaled corticosteroid particle size on asthma efficacy and safety outcomes: a systematic literature review and meta-analysis.

El Baou C, Di Santostefano RL, Alfonso-Cristancho R, Suarez EA, Stempel D, Everard ML, Barnes N.

BMC Pulm Med. 2017 Feb 7;17(1):31. doi: 10.1186/s12890-016-0348-4. Review. Erratum in: BMC Pulm Med. 2017 Dec 5;17 (1):172.

13.

Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.

Kramer S, Rottier BL, Scholten RJ, Boluyt N.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD010352. doi: 10.1002/14651858.CD010352. Review.

PMID:
23450613
14.

Mobile phone messaging for facilitating self-management of long-term illnesses.

de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD007459. doi: 10.1002/14651858.CD007459.pub2. Review.

15.

Interventions for bronchiectasis: an overview of Cochrane systematic reviews.

Welsh EJ, Evans DJ, Fowler SJ, Spencer S.

Cochrane Database Syst Rev. 2015 Jul 14;(7):CD010337. doi: 10.1002/14651858.CD010337.pub2. Review.

PMID:
26171905
16.

Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease.

Pollok J, van Agteren JE, Esterman AJ, Carson-Chahhoud KV.

Cochrane Database Syst Rev. 2019 Mar 6;3:CD012347. doi: 10.1002/14651858.CD012347.pub2.

PMID:
30838649
17.

Airway clearance devices for cystic fibrosis: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2009;9(26):1-50. Epub 2009 Nov 1.

18.

Weight loss interventions for chronic asthma.

Adeniyi FB, Young T.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD009339. doi: 10.1002/14651858.CD009339.pub2. Review.

PMID:
22786526
19.

Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation.

Norman G, Faria R, Paton F, Llewellyn A, Fox D, Palmer S, Clifton I, Paton J, Woolacott N, McKenna C.

Health Technol Assess. 2013 Nov;17(52):1-342. doi: 10.3310/hta17520. Review.

20.

Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial.

Brightling CE, Chanez P, Leigh R, O'Byrne PM, Korn S, She D, May RD, Streicher K, Ranade K, Piper E.

Lancet Respir Med. 2015 Sep;3(9):692-701. doi: 10.1016/S2213-2600(15)00197-6. Epub 2015 Jul 28.

PMID:
26231288

Supplemental Content

Support Center